These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6820959)
1. Preclinical ocular evaluation of noncorticosteroidal antiinflammatory agents. Murray DL; Leopold IH Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):201-8. PubMed ID: 6820959 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandins and inflammation in the eye. Nelson EL Mod Probl Ophthalmol; 1976; 16():125-30. PubMed ID: 765779 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and inflammatory reactions in the eye. Bhattacherjee P Methods Find Exp Clin Pharmacol; 1980 Feb; 2(1):17-31. PubMed ID: 6803089 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostaglandin-mediated ocular inflammatory responses by 4-biphenylacetic acid. Tolman EL; Partridge R; Myers TO; Birnbaum JE Invest Ophthalmol; 1976 Dec; 15(12):1005-8. PubMed ID: 1086849 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of topical ocular MAXIDEX administration to rabbits following vitrectomy or lensectomy. Scheib SA; Garner WH Exp Eye Res; 2004 Dec; 79(6):893-902. PubMed ID: 15642327 [TBL] [Abstract][Full Text] [Related]
6. [New aspects of inflammation prevention by means of non-steroid antiphlogistics: the effect of Voltaren]. Krupp P; Exer B; Menassé R; Ziel R Schweiz Med Wochenschr; 1975 May; 105(20):646-52. PubMed ID: 1215867 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of some steroidal compounds in ocular inflammation. Ruggieri PD; La Macchia G; Rigamonti G; Sighinolfi O; Villa G Farmaco Sci; 1976 Dec; 31(12):849-55. PubMed ID: 1087906 [TBL] [Abstract][Full Text] [Related]
8. Effects of various pharmacologic agents on allergic inflammation of the eye. The roles of chemical mediators in ocular inflammation. Okada M; Shimada K Invest Ophthalmol Vis Sci; 1980 Feb; 19(2):176-81. PubMed ID: 6101322 [TBL] [Abstract][Full Text] [Related]
10. Problems of ocular immunopathological inflammations. Böke W Mod Probl Ophthalmol; 1976; 16():1-7. PubMed ID: 129674 [TBL] [Abstract][Full Text] [Related]
11. Use of anti-inflammatory agents in destructive corneal disease. Smolin G Trans Ophthalmol Soc U K (1962); 1978 Sep; 98(3):406-9. PubMed ID: 382459 [TBL] [Abstract][Full Text] [Related]
12. The potential role of prostaglandins in skeletal and muscular disorders. Zurier RB Ann Clin Lab Sci; 1975; 5(4):276-81. PubMed ID: 1163993 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandins in ocular pathophysiology with special reference to diabetic retinopathy and glaucoma. Waitzman MB; Colley AM Metab Pediatr Syst Ophthalmol; 1983; 7(1):7-23. PubMed ID: 6353134 [TBL] [Abstract][Full Text] [Related]
14. [Ophthalmic drug films in the treatment of inflammatory diseases of the eyeball]. Pen'kov MA; Avrushchenko NM; Khristenko LA Oftalmol Zh; 1978; (6):431-3. PubMed ID: 362272 [No Abstract] [Full Text] [Related]
15. Cyclopentenone prostaglandins-new allies in the war on inflammation. Willoughby DA; Moore AR; Colville-Nash PR Nat Med; 2000 Feb; 6(2):137-8. PubMed ID: 10655096 [No Abstract] [Full Text] [Related]
16. Prostaglandins, immunity and their effect on tumour growth. Ablin RJ Allergol Immunopathol (Madr); 1985; 13(2):157-60. PubMed ID: 3890502 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandins and inflammation. Di Rosa M; Parente L Mater Med Pol; 1980; 12(3):187-94. PubMed ID: 6789011 [No Abstract] [Full Text] [Related] [Next] [New Search]